{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:32:24Z","timestamp":1794227544965,"version":"4.9.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare vitreous substitution with silicone oil to perfluoropropane gas in proliferative diabetic retinopathy subjects undergoing pars plana vitrectomy (PPV) for the treatment of tractional retinal detachment or extensive fibrous proliferation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Randomized clinical trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Three hundred and two proliferative diabetic retinopathy subjects with tractional retinal detachment or extensive fibrous proliferation requiring PPV were enrolled into the trial. Subjects were prospectively randomized into one of two vitreous substitution groups during PPV: Group A subjects underwent 1,000 centistoke silicone oil tamponade, whereas Group B subjects underwent 14% to 16% silicone oil to perfluoropropane gas tamponade. The principal outcome was the best-corrected visual acuity at 6-month follow-up. Secondary outcomes were postoperative complications and unplanned PPV during the 6-month trial interval.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Two hundred and fifty-eight subjects were randomized to receive a vitreous substitute and completed 6-month follow-up. Group B had better best-corrected visual acuity, more subjects ending up with 0.4 logarithm of the minimum angle of resolution (20\/50) or better visual acuity, and more subjects ending up with 1 logarithm of the minimum angle of resolution (20\/200) or better visual acuity at 6 months compared with Group A (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001, respectively). There were no significant differences in baseline characteristics, intraoperative or postoperative complications, or incidence of unplanned PPV between groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This trial demonstrated that vitreous substitution with silicone oil to perfluoropropane gas resulted in better visual acuity at 6 months compared with silicone oil tamponade in proliferative diabetic retinopathy patients undergoing PPV for tractional retinal detachment or extensive fibrous proliferation. Surgeons should consider silicone oil to perfluoropropane gas tamponade as the first-line vitreous substitute in this patient population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003052","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T22:03:39Z","timestamp":1606341819000},"page":"1407-1415","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["SILICONE OIL VERSUS PERFLUOROPROPANE GAS TAMPONADE DURING VITRECTOMY FOR TRACTIONAL RETINAL DETACHMENT OR FIBROUS PROLIFERATION"],"prefix":"10.1097","volume":"41","author":[{"given":"Ryan B.","family":"Rush","sequence":"first","affiliation":[{"name":"Instituto de la Visi\u00f3n\u2014Hospital La Carlota, Nuevo Le\u00f3n, M\u00e9xico;"},{"name":"Panhandle Eye Group, Amarillo, Texas;"},{"name":"Texas Tech University Health Science Center, Amarillo, Texas;"},{"name":"Southwest Retina Specialists, Amarillo, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Del Valle Penella","sequence":"additional","affiliation":[{"name":"Instituto de la Visi\u00f3n\u2014Hospital La Carlota, Nuevo Le\u00f3n, M\u00e9xico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Reinauer","sequence":"additional","affiliation":[{"name":"Instituto de la Visi\u00f3n\u2014Hospital La Carlota, Nuevo Le\u00f3n, M\u00e9xico;"},{"name":"New Vision Eye Center, Vero Beach, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sloan W.","family":"Rush","sequence":"additional","affiliation":[{"name":"Panhandle Eye Group, Amarillo, Texas;"},{"name":"Texas Tech University Health Science Center, Amarillo, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro G.","family":"Bastar","sequence":"additional","affiliation":[{"name":"Instituto de la Visi\u00f3n\u2014Hospital La Carlota, Nuevo Le\u00f3n, M\u00e9xico;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0161-6420(98)96025-0","article-title":"The 14-year incidence of visual loss in diabetic population","volume":"105","author":"Moss","year":"1998","journal-title":"Ophthalmology"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0891-6632(88)90004-9","article-title":"Vitrectomy for complications of proliferative diabetic retinopathy","volume":"2","author":"Michels","year":"1988","journal-title":"J Diabetic Complications"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/eye.2011.348","article-title":"Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice","volume":"26","author":"Gupta","year":"2012","journal-title":"Eye (Lond)"},{"key":"R4-20250607","first-page":"CD006126","article-title":"Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy","volume":"2","author":"Schwartz","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3341\/kjo.2016.0018","article-title":"Predictors and outcomes of vitrectomy and silicone oil injection in advanced diabetic retinopathy","volume":"31","author":"Ramezani","year":"2017","journal-title":"Korean J Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1076\/soph.18.3.121.29811","article-title":"Use of viscodissection and silicone oil in vitrectomy for severe diabetic retinopathy","volume":"18","author":"Grigorian","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.survophthal.2019.04.008","article-title":"Surgical management of diabetic tractional retinal detachments","volume":"64","author":"Iyer","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.ophtha.2011.03.036","article-title":"The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy","volume":"118","author":"Ahn","year":"2011","journal-title":"Ophthalmology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/IAE.0b013e3181853d3c","article-title":"Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment","volume":"28","author":"Altan","year":"2008","journal-title":"Retina"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/bjo.87.3.318","article-title":"Vitrectomy with silicone oil infusion in severe diabetic retinopathy","volume":"87","author":"Castellarin","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00417-011-1873-8","article-title":"Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months","volume":"250","author":"Morphis","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bjo.77.4.204","article-title":"Removal of silicone oil following diabetic vitrectomy","volume":"77","author":"Pearson","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02144135","article-title":"Silicone-oil injection during closed microsurgery for diabetic retinal detachment","volume":"224","author":"McLeod","year":"1986","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02764284","article-title":"Intravitreal silicone oil injection: complications and treatment of 415 consecutive patients","volume":"228","author":"Riedel","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/eye.2015.126","article-title":"Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment","volume":"29","author":"Dikopf","year":"2015","journal-title":"Eye (Lond)"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/aos.12325","article-title":"Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study","volume":"92","author":"Ostri","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bjo.2007.124495","article-title":"Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy","volume":"92","author":"Yorston","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamaophthalmol.2015.4587","article-title":"The royal college of ophthalmologists' national ophthalmology database study of vitreoretinal surgery: report 6, diabetic vitrectomy","volume":"134","author":"Jackson","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"R19-20250607","first-page":"29","article-title":"Iatrogenic retinal breaks during 20-gauge vitrectomy for proliferative diabetic retinopathy","volume":"7","author":"Kamura","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1755-3768.2011.02248.x","article-title":"Visual loss after use of intraocular silicone oil associated with thinning of inner retinal layers","volume":"90","author":"Christensen","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bjo.2004.053561","article-title":"Visual loss following removal of intraocular silicone oil","volume":"89","author":"Cazabon","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bjo.2005.082610","article-title":"Visual loss after silicone oil removal","volume":"89","author":"Herbert","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/IAE.0000000000002093","article-title":"Bimanual microincision vitreous surgery for severe proliferative diabetic retinopathy: outcome IN more than 300 eyes","volume":"38","author":"Shroff","year":"2018","journal-title":"Retina"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0161-6420(83)34526-7","article-title":"Complications of vitreous surgery for diabetic retinopathy. (I. Postoperative complications)","volume":"90","author":"Oyakawa","year":"1983","journal-title":"Ophthalmology"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0161-6420(83)34540-1","article-title":"Complications of vitreous surgery for diabetic retinopathy (II. Postoperative complications)","volume":"90","author":"Schachat","year":"1983","journal-title":"Ophthalmology"},{"key":"R26-20250607","first-page":"671","article-title":"The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy","volume":"6","author":"Qamar","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/IAE.0b013e3181d374a5","article-title":"Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment","volume":"30","author":"Tao","year":"2010","journal-title":"Retina"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/IAE.0000000000001793","article-title":"Visual and anatomical outcomes after diabetic traction and traction rhegmatogenous retinal detachment repair","volume":"38","author":"Storey","year":"2018","journal-title":"Retina"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ophtha.2006.07.047","article-title":"Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy","volume":"114","author":"Yang","year":"2007","journal-title":"Ophthalmology"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1755-3768.2008.01498.x","article-title":"Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment","volume":"88","author":"Yeung","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R31-20250607","first-page":"105","article-title":"Sulfur hexafluoride 20% versus lactated Ringer's solution for prevention of early postoperative vitreous hemorrhage after diabetic vitrectomy","volume":"5","author":"Farrahi","year":"2010","journal-title":"J Ophthalmic Vis Res"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:04:47Z","timestamp":1749319487000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003052"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003052","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}